RAC 2.20% $1.78 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-6

  1. 7,149 Posts.
    lightbulb Created with Sketch. 1832
    Impressive results and impressive writing Dr.T. No questions spring to mind. Looks like you have laid it out in human readable form and Eddy doesn’t have it to run it thru chatgpt grade 1 level for folks like me

    Can I ask if the data for you to make this announcement is limited to the poster or do you have more info? I don’t see any charts or other such information that you would normally include, hence curious.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.